Business Context and Reporting Period
This Form 8-K Current Report was filed by Global Medical REIT Inc. on August 17, 2018. The filing reports the entry into a new Material Definitive Agreement and the termination of prior agreements regarding the sale of common stock. Note: The request metadata references "Chiron Real Estate Inc.," but the filing text explicitly identifies the registrant as Global Medical REIT Inc.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital raising activities.
- Aggregate Offering Amount: Up to $50,000,000 in gross proceeds from the sale of common stock.
- Compensation to Agents: Up to 3.0% of gross proceeds from shares sold through the agents.
- Stock Par Value: $0.001 per share.
Material Changes
The Company entered into a new Sales Agreement on August 17, 2018, with multiple agents including Cantor Fitzgerald & Co., B. Riley FBR, Inc., BMO Capital Markets Corp., D.A. Davidson & Co., H.C. Wainwright & Co., LLC, The Huntington Investment Company, and Robert W. Baird & Co. Incorporated. This agreement allows for "at the market" offerings of common stock. Concurrently, the Company terminated prior sales agreements dated August 25, 2017, with Cantor Fitzgerald & Co. and B. Riley FBR, Inc. The new aggregate offering amount includes shares previously sold under the terminated agreements.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance or management commentary on future earnings. The Company retains the discretion to suspend solicitations of offers to buy or sell shares at any time and has no obligation to sell any shares under the new agreement. The shares are issued pursuant to a Registration Statement on Form S-3. The filing includes standard legal disclaimers regarding the legality of the shares and the requirement for state registration or qualification before any sale.
Investor Verification Checklist
- Verify the exact number of shares sold to date under the new Sales Agreement versus the prior terminated agreements.
- Confirm the current market price of Global Medical REIT Inc. common stock to assess the potential dilution impact of the $50,000,000 offering.
- Review the full text of the Sales Agreement (Exhibit 1.1) for specific termination rights and conditions.
- Check subsequent filings to determine if the Company has actually executed sales under this new agreement.